-
HLY78: Wnt/β-catenin pathway modulator
2026-09-21
HLY78 enables ligand-dependent interrogation of the Axin-LRP6 signaling node, making it useful for mechanistic cell assays and zebrafish developmental studies. This workflow also shows how findings from oral fibrosis research can guide assay design without overstating therapeutic relevance.
-
Cisplatin Workflows for DNA Damage and Apoptosis
2026-09-21
Build reproducible CDDP models that connect DNA crosslinking with viability, apoptosis, oxidative stress, and rescue biology. This workflow also translates a placental mesenchymal stem cell exosome study into practical ovarian granulosa cell assay choices.
-
BMS 309403: A Translational FABP4 Roadmap
2026-09-20
A mechanistic and strategic guide to using BMS 309403 to interrogate the SERCA2–calcineurin–FoxO1–FABP4 axis, foam-cell biology, atherosclerosis, and metabolic dysfunction.
-
Homoharringtonine and Rapid SARS-CoV-2 Clearance
2026-09-19
The reference study identifies Homoharringtonine as a host-directed cytotoxic alkaloid that suppresses coronavirus protein elongation and rapidly reduces SARS-CoV-2 in cell, animal, and small human pilot studies. Its cross-domain relevance is substantial for SARS-CoV-2 antiviral research, but the evidence remains preliminary and does not replace controlled clinical evaluation.
-
Palbociclib (PD0332991) Isethionate in Cell Assays
2026-09-18
This scenario-based guide explains how Palbociclib (PD0332991) Isethionate, SKU A8335, can improve interpretation of cell-cycle, viability, and cytotoxicity experiments. It covers mechanism-aware assay design, solvent and storage controls, model comparison, and practical supplier selection supported by product data and current cancer biology research.
-
ac4C–Gm26917 Control of Translation in FGSCs
2026-09-18
This study identifies an ac4C–Gm26917–EEF1A1–Rpl10 pathway that connects long noncoding RNA modification with ribosome-associated translation control in female germline stem cells. Its integrated use of acRIP-seq, RIC-seq, and Ribo-seq shows that ac4C can regulate translation indirectly by preserving lncRNA structure and RNA–protein interactions.
-
IDO1 Inhibition and Tumor-Protective JAK2/STAT3
2026-09-17
This study shows that pharmacological IDO1 inhibition can produce a paradoxical tumor-protective response: immune cells become more active, yet myeloid-derived IL-6 stimulates tumor-intrinsic JAK2/STAT3 signaling. Single-cell RNA sequencing in a syngeneic CT26 model provides a rationale for combining IDO1 blockade with inhibitors of the IL-6/JAK2/STAT3 axis.
-
AZD1480: Turning JAK2/STAT3 Escape Into Insight
2026-09-17
A translational framework for using AZD1480, an ATP-competitive JAK2 inhibitor, to dissect tumor-intrinsic STAT3 survival programs, validate adaptive resistance mechanisms, and strengthen combination study design.
-
BMS 309403 Workflows for FABP4 Research
2026-09-16
BMS 309403 provides a selective, reversible way to interrogate FABP4 in macrophage inflammation, lipid handling, and foam-cell biology. This workflow guide connects cell-based dose finding with the SERCA2–calcineurin–FoxO1–FABP4 axis relevant to atherosclerosis and metabolic disease research.
-
CLK2–BRCA1 Signaling in Platinum-Resistant Ovarian Cancer
2026-09-16
The reference study identifies Cdc2-like kinase 2 (CLK2) as a clinically associated and functionally active driver of platinum resistance in ovarian cancer. Its central mechanistic finding is that CLK2 phosphorylates BRCA1 at Ser1423 to enhance DNA damage repair, while platinum-associated p38 signaling stabilizes CLK2, suggesting a stress-adaptive resistance pathway that can be tested in cell and xenograft models.
-
AMPK–SQSTM1 Feedback Under Metabolic Stress
2026-09-15
The 2024 Autophagy study identifies a double-positive feedback loop in which SQSTM1/p62 and AMPK reinforce one another during metabolic stress, jointly activating NRF2-dependent antioxidant defense. Its mechanistic framework connects lysosomal deacidification, TFEB/TFE3 regulation, ROS-dependent TAK1 signaling, and cancer-cell adaptation, while suggesting experimentally testable points for disrupting stress tolerance.
-
Clathrin-Mediated Entry of Type III Grass Carp Reovirus
2026-09-15
Wang et al. used pharmacological inhibition, transmission electron microscopy, and RT-qPCR to show that genotype III grass carp reovirus enters CIK cells through a dynamin-dependent, clathrin-mediated pathway that requires endosomal acidification. The study also found that nocodazole-sensitive microtubule disruption did not significantly block entry, helping distinguish endocytic requirements from broader cytoskeletal effects.
-
Chloroquine Diphosphate: Autophagy Workflows
2026-09-14
Build more interpretable autophagy assay, chemotherapy sensitization, and lysosome-function experiments with a water-soluble research reagent. This guide connects concentration planning and flux-aware controls with a recent JEV lysosome study, while clearly separating validated findings from practical starting conditions.
-
Myriocin: SPT Inhibition in Lipid Research
2026-09-14
Myriocin enables controlled suppression of de novo sphingolipid synthesis for mechanistic studies spanning ceramide biology, cancer research, and immunology. This workflow-focused guide shows how to pair pharmacological SPT inhibition with lipid, viability, apoptosis, and cell-cycle readouts for more interpretable experiments.
-
Berberine, RXRα/PPARγ, and SASP in Atherosclerosis
2026-09-13
The 2025 reference study identifies an RXRα/PPARγ/NEDD4 pathway through which berberine suppresses senescence-associated secretory phenotype inflammation in macrophage-derived foam cells and atherosclerotic plaques. Its combination of Smart-seq analysis, foam-cell experiments, plaque phenotyping, and macrophage-specific RXRα knockdown provides a mechanistic framework for studying nuclear-receptor control of vascular inflammation.